Investors finally get a glimpse of Clover Health Investments Corp (CLOV) volume hitting the figure of 13.05 million.

A new trading day began on Friday, with Clover Health Investments Corp (NASDAQ: CLOV) stock price up 6.39% from the previous day of trading, before settling in for the closing price of $2.66. CLOV’s price has ranged from $0.61 to $2.71 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 52.25% over the past five years. Meanwhile, its annual earnings per share averaged 71.11%. With a float of $375.67 million, this company’s outstanding shares have now reached $393.27 million.

Let’s look at the performance matrix of the company that is accounted for 552 employees. In terms of profitability, gross margin is 29.74%, operating margin of -7.23%, and the pretax margin is -7.57%.

Clover Health Investments Corp (CLOV) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Healthcare Plans Industry. The insider ownership of Clover Health Investments Corp is 24.41%, while institutional ownership is 14.86%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.

Clover Health Investments Corp (CLOV) Latest Financial update

In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.09 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 71.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.

Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators

Here are Clover Health Investments Corp’s current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.83.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.12 in one year’s time.

Technical Analysis of Clover Health Investments Corp (CLOV)

Clover Health Investments Corp (NASDAQ: CLOV) saw its 5-day average volume 12.97 million, a positive change from its year-to-date volume of 7.58 million. As of the previous 9 days, the stock’s Stochastic%D was 95.52%. Additionally, its Average True Range was 0.19.

During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 96.95%, which indicates a significant increase from 95.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 129.91% in the past 14 days, which was higher than the 89.19% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.54, while its 200-day Moving Average is $1.06. Nevertheless, the first resistance level for the watch stands at $2.94 in the near term. At $3.06, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.21. If the price goes on to break the first support level at $2.67, it is likely to go to the next support level at $2.52. The third support level lies at $2.40 if the price breaches the second support level.

Clover Health Investments Corp (NASDAQ: CLOV) Key Stats

With a market capitalization of 1.41 billion, the company has a total of 496,437K Shares Outstanding. Currently, annual sales are 2,034 M while annual income is -213,360 K. The company’s previous quarter sales were 356,260 K while its latest quarter income was 7,410 K.